-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Upgrades United Therapeutics to Buy, Announces $728 Price Target

Benzinga·10/01/2026 09:54:14
語音播報
BTIG analyst Julian Harrison upgrades United Therapeutics (NASDAQ:UTHR) from Neutral to Buy and announces $728 price target.